ID: ALA5193399

Max Phase: Preclinical

Molecular Formula: C29H44N2O9

Molecular Weight: 564.68

Associated Items:

Representations

Canonical SMILES:  CNC(=O)O[C@@H]1[C@@H](/C=C/C(C)=C/C[C@@H]2O[C@H](C)[C@H](NC(=O)/C=C\[C@H](C)OC(C)=O)C[C@@H]2C)O[C@H](OC)C[C@@]12CO2

Standard InChI:  InChI=1S/C29H44N2O9/c1-17(9-12-24-27(40-28(34)30-6)29(16-36-29)15-26(35-7)39-24)8-11-23-18(2)14-22(20(4)38-23)31-25(33)13-10-19(3)37-21(5)32/h8-10,12-13,18-20,22-24,26-27H,11,14-16H2,1-7H3,(H,30,34)(H,31,33)/b12-9+,13-10-,17-8+/t18-,19-,20+,22+,23-,24+,26-,27+,29+/m0/s1

Standard InChI Key:  LPMOWOJLXVRHRE-VQXBQXHJSA-N

Associated Targets(Human)

MES-SA/Dx5 643 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MES-SA 905 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEK-293T 167025 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 564.68Molecular Weight (Monoisotopic): 564.3047AlogP: 2.94#Rotatable Bonds: 10
Polar Surface Area: 133.95Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 2.62CX LogD: 2.62
Aromatic Rings: 0Heavy Atoms: 40QED Weighted: 0.18Np Likeness Score: 2.27

References

1. Ghosh AK, Mishevich JL, Jurica MS..  (2021)  Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.,  84  (5.0): [PMID:33974423] [10.1021/acs.jnatprod.1c00100]

Source